PMC7596010_01
Prostatic MRI showing found a lesion of the right posterolateral area classified as PIRADS 4.
gr1.jpg
PMC7596010_01_gr1.jpg
fig0005
PSA testing achieved was 10.83 ng / ml. Prostatic MRI performed on 10/12/2019 found a lesion of the right posterolateral area classified as PIRADS 4 (Fig. 1).
Axial and coronal computed tomography image reveals a process of the excretory tract in the left renal and a lower right polar renal lesion.
gr2.jpg
PMC7596010_01_gr2.jpg
fig0010
A computed tomography of the abdomen and pelvis performed on 10/26/2019 revealed left ureterohydronephrosis with a 14 x 12 mm middle and lower calyceal excretory tract tumor on the left and a lower right polar renal tumor of 27, 6 x 26.4 enhancing after injection of contrast medium (Fig. 2). the cystoscopy was normal
PET-CT 18-FDG a confirms a hypermetabolic focus of the right prostate lobe, with hypofixed irregularity of the right postero-lateral renal.
gr3.jpg
PMC7596010_01_gr3.jpg
fig0015
Positron emission tomography - Computed tomography (PET-CT) with 18-FDG confirmed a hypermetabolic focus of the right lobe of the prostate, with a hypofixed irregularity of the right posterolateral renal contour (Fig. 3).
The left nephroureterectomy image showing a tumor in the excretory tract.
gr4.jpg
PMC7596010_01_gr4.jpg
fig0020